Abstract A16: Antitumor activity of CYT997: A phase II vascular disrupting agent administered orally in combination with cisplatin in a colon adenocarcinoma xenograft model
Year: 2009
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Authors: Andrew K. Powell, Steven D. Shnyder, Patricia A. Cooper, Stuart Nelson, Christopher J. Burns, Rose Fida, Gregg D. Smith
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1968209682